Tweet
IBM is in the pipeline. Obviously they have deep pockets.
-
-
They're also being helped out by NHGRI grants, although I'm sure that money doesn't go all that far in developing a new technology and instrument to run it:Originally posted by NextGenSeq View Post
"The firm is one of several companies or researchers that have been awarded at least $5.7 million from the National Human Genome Research Institute this year to support their efforts in developing technologies for sequencing a human genome at low cost."
-
3rd article, guess they were stealth for quite a while. Competition is good. Hope they give PacBio a run for the money (thanks forum sponsors!)
Comment
-
The more skeptical amongst you might have noticed that this press release (containing few/no details beyond previous, very old announcements) came out at a similar time to the announcement of the Justice department's anti-trust probe into IBM...Last edited by 454newbie; 03-08-2011, 10:28 AM.Comment
-
Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.
The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
...06-02-2026, 10:05 AM -
With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.
Introduction
Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...05-22-2026, 06:42 AM
Comment